Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

The proof-of-concept study is one of the first to combine B and T cell analysis and potentially paves the way for tests that ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8 mL dose.

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

When COVID-19 vaccines rolled out, public health officials largely followed a simple logic: protect the most vulnerable first ...

COVID-19 showed the flaws in our approach to vaccine communication. Two public health experts suggest ways to fix them.

Vector-borne zoonotic diseases, transmitted by pathogens via arthropods like mosquitoes, ticks, and fleas, comprise 17% of the global infectious disease ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...

The new strain of the virus (pictured) first arrived in England in November 2023 but has quickly spread, with the so-called ...

The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...